or
Bookmark and Share
ST104P, an anti-angiogenic agent
   
Document Number
US Patent 7273890
Issued Date
September 25, 2007
Link
Inventors
Map
Abstract
The anti-angiogenic functions of a polysulfated, cyclic compound, ST104P, were investigated. ST104P exhibited excellent water solubility and low cytotoxicity to endothelial cells. ST104P potently inhibited the secretion of matrix metalloproteinase (MMPs) by endothelial cells. Moreover, ST104 also perturbed the migration and tube formation of endothelial cells. Application of ST104P abolished the neovascularization in chicken choroiallantoic membrane (CAM) in a dose-dependent manner. Besides, repeated administration of ST104P into Lewis lung carcinoma resulted in delayed tumor growth and prolonged the life span of tumor-bearing mice. These results indicated that ST104P inhibited angiogenesis and may hold promises for treatment of cancer and diseases or conditions caused by excessive angiogenesis.
Drawing
ST104P, an anti-angiogenic agent - US Patent 7273890 Drawing
Drawing from US Patent 7273890
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
8
Comments:
no comments yet
Owner
Sagittarius Life Science Corp. (Linkou Hsiang, Taipei Shien,TW)
Published
September 25, 2007
Application Number
10/865,480
Filed
June 8, 2004
US Classification
514/732  
Int'l Classification
A61K   31/05   (20060101)  
Examiner
Assistant Examiner
Attorney/Law Firm
USPTO Field of Search
Related Patents
Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us